Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

BelgiumBack to Belgium

Clinical trials in Antwerp – page 9

237 clinical trials in Antwerp, Belgium across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Antwerp at a glance
237
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

237 trials in Antwerp

Open in trial search

Respiratory syncytial virus infection

Not recruiting

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:GlaxoSmithKline Biologicals

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Neoplasm

Not recruiting

Study on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ACP-017
  • Sponsor:Ascendis Pharma Oncology Division A/S

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Type 2 diabetes mellitus

Not recruiting

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Rheumatoid arthritis

Not recruiting

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Safety, Tolerability, PK and PD of Nipocalimab (JNJ-80202135) Subcutaneous Injection via Syringe or Prefilled Autoinjector in Healthy Volunteers

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Inflammation

Not recruiting

A study to evaluate how JNJ-77242113 is absorbed by the body in healthy participants for the treatment of inflammatory diseases.

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Janssen Cilag International

Study of Aticaprant Oral Tablet vs Small IV Dose to Measure How Well It Is Absorbed in Healthy Adults

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Hormone-dependent prostate cancer+1

Not recruiting

A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Antwerp

What the registry says about research in the country

01 Infectious Disease Research

Clinical trials focusing on preventive vaccines and treatments for various infectious diseases, including studies on influenza, rabies, and yellow fever immunization strategies.

  • Influenza vaccine safety and immune response studies
  • Rabies vaccination route comparison
  • Yellow fever vaccine immunogenicity research

Research includes innovative vaccination techniques and immune response evaluation in different age groups.

02 Cancer Research

Comprehensive studies on various cancer types, with particular focus on leukemia and breast cancer treatments.

  • Triple-negative breast cancer therapy trials
  • Acute Myeloid Leukemia treatments
  • Chronic lymphocytic leukemia interventions

Investigating novel drug combinations and personalized treatment approaches for better patient outcomes.

03 Antimicrobial Research

Studies examining antimicrobial resistance and treatment optimization in various bacterial infections.

  • E. coli resistance studies
  • Antibiotic dosing strategies
  • Infection prevention protocols

Focus on developing effective antimicrobial strategies while minimizing resistance development.

Back to BelgiumAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.